Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Acq. announced
REPLIGEN CORP (RGEN) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/20/2021 GN Repligen to Report First Quarter 2021 Financial Results
03/03/2021 GN Repligen Corporation to Present at Barclays Global Healthcare Conference
02/24/2021 GN Repligen Reports Fourth Quarter and Full Year 2020 Financial Results
02/22/2021 GN Repligen Corporation to Present at 10th Annual SVB Leerink Healthcare Conference
02/11/2021 GN Repligen to Report Fourth Quarter and Full Year 2020 Financial Results
02/08/2021 GN Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines
01/04/2021 GN Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
12/10/2020 GN Repligen Corporation Announces Closing of Public Offering of $312.2 Million, Including Full Exercise of Underwriters' Option
12/07/2020 GN Repligen Corporation Prices Public Offering of Shares of Common Stock
12/07/2020 GN Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
11/05/2020 GN Repligen Reports Third Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
10/27/2020 GN Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy